LOWATOR

This brand name is authorized in Nigeria.

Active ingredients

The drug LOWATOR contains one active pharmaceutical ingredient (API):

1	Rosuvastatin UNII 83MVU38M7Q - ROSUVASTATIN CALCIUM
	Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.
	Read more about Rosuvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9432	Tablet	LOWATOR 10MG TABLETS TAB 10 mg 3x10	56 RNW-PP-316361 LOWATOR 10MG TABLETS ROSUVASTATIN 10mg Rosuvastatin calcium eqv. to rosuvastatin 10mg B4-9432 Drugs Imported Products 3X10 Prescription Only Medicine (POM) 3/22/2023 UNOSOURCE PHARMA NIGERIA LIMITED, 47, Babaponmile Street, Onipetesi-Mongoro 234803854 unosourcepharmangltd@yahoo.com AKUMS DRUGS & PHARM LIMITED, 19.20.21,SECTOR 6A,I.I.E.BHEL AREA SIDCUL RANIPUR,HARDIWAR.INDIA, India	31/01/2024
B4-9433	Tablet	LOWATOR-5 TABLET TAB 5 mg 3x10	42 RNW-PP-362342 LOWATOR-5 TABLET ROSUVASTATIN TABLET USP 5MG ROSUVASTATIN TABLET USP 5MG, Excipients: Dibasic Calcium phosphate, lactose anhydrous, microcrystalline cellulose, pregelatinised starch, colour sunset yellow fcf lake, hydroxy propyl cellulose (KLUCEL EXF), Isopropyl alchohol, magnesium stearate, colloidal anhydrous silica, sodium starch glycolate (primojel) crospovidone B4-9433 Drugs Imported Products 3x10 Prescription Only Medicine (POM) 10/30/2023 UNOSOURCE PHARMA NIGERIA LIMITED, 47,BABAPOMILE STREET,ONIPETESI ESTATE, MANGORO, LAGOS." AKUMS DRUGS & PHARMACEUTICALS LIMITED, 19, 20, 21, SECTOR-6A, I.I.E., SIDCUL, RANIPUR, HARIDWAR-249403, INDIA., India	27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA07	Rosuvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9432, B4-9433